Literature DB >> 16500024

New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.

Vicente Medina-Arana1, Ysamar Barrios, Antonia Fernández-Peralta, Mercedes Herrera, Nancy Chinea, Nieves Lorenzo, Alejandro Jiménez, Juana Victoria Martín-López, Fernando González-Hermoso, Eduardo Salido, Juan J González-Aguilera.   

Abstract

Lynch syndrome or hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary syndrome with genetic heterogeneity. The disease is caused by mutations or epigenetic silencing in DNA mismatch repair genes, MLH1, MSH2, MSH6, PMS2 and MLH3, although the vast majority of cases correspond to mutations of MLH1 and MSH2. We herein describe a nucleotide change, c.2063T>G in exon 13 of the MSH2 gene, present in families that fulfill the Amsterdam criteria for Lynch syndrome and originate from northern Tenerife (Canary Islands-Spain). This mutation is expected to result in a nonconservative amino acid change, M688R, at the ATPase domain of the MSH2 protein. We found five large families with this mutation, and about half the individuals heterozygous for M688R developed malignancies by the sixth decade of life. In many cases analyzed, their tumors revealed loss of the normal allele, being homozygous for M688R. There is an evidence of historical isolation for the population studied, which could have favored a considerable genetic drift. The presence of the same mutation and the disease associated-haplotype conservation in families not directly related can be probably the consequence of a bottleneck in the founding of this population (rather than a relatively recent founding of the mutation).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500024     DOI: 10.1016/j.canlet.2005.12.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Authors:  Juana V Martín-López; Ysamar Barrios; Vicente Medina-Arana; Miguel Andújar; Sanghee Lee; Liya Gu; Guo-Min Li; Josef Rüschoff; Eduardo Salido; Richard Fishel
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

2.  Single nucleotide polymorphisms of DNA mismatch repair genes MSH2 and MLH1 confer susceptibility to esophageal cancer.

Authors:  Ming-Zhong Sun; Hui-Xiang Ju; Zhong-Wei Zhou; Hao Jin; Rong Zhu
Journal:  Int J Clin Exp Med       Date:  2014-08-15

3.  Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.

Authors:  V Medina-Arana; L Delgado; L González; A Bravo; H Díaz; E Salido; D Riverol; J J González-Aguilera; A M Fernández-Peralta
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability.

Authors:  Luciano Delgado-Plasencia; Vicente Medina-Arana; Alberto Bravo-Gutiérrez; Julián Pérez-Palma; Hugo Álvarez-Argüelles; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2013-02-20       Impact factor: 2.571

5.  G-C heterozygosis in mutS homolog2 as a risk factor to hereditary nonpolyposis colon cancer in the absence of a family medical history.

Authors:  Jorge Alfonso Arvayo-Zatarain; José Manuel Grijalva-Chon; Reina Castro-Longoria; Alejandro Varela-Romero
Journal:  Indian J Hum Genet       Date:  2011-05

6.  Mutation spectrum in South American Lynch syndrome families.

Authors:  Mev Dominguez-Valentin; Mef Nilbert; Patrik Wernhoff; Francisco López-Köstner; Carlos Vaccaro; Carlos Sarroca; Edenir Ines Palmero; Alejandro Giraldo; Patricia Ashton-Prolla; Karin Alvarez; Alejandra Ferro; Florencia Neffa; Junea Caris; Dirce M Carraro; Benedito M Rossi
Journal:  Hered Cancer Clin Pract       Date:  2013-12-18       Impact factor: 2.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.